Drawing for VIVAGEL

USPTO serial 79029045

VIVAGEL

Reviewed by CopyMark Law Group

Reg. 3784858Status 709
Filing date
Status date
Registration date
May 4, 2010
Examiner
RINGLE, JAMES W
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIVAGEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, pharmaceutical preparations, and drugs for medical purposes for treatment and prevention of [ viral, ] fungal and bacterial disease, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV)] ; [ chemical and biological preparations, ] substances for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; [ reagents and ] compounds for medical purposes; polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; antimicrobial preparations, namely, microbicidal preparations in the nature of gels [, foams, creams, films, solutions, suppositories, suspensions and lotions ] for vaginal [, rectal and transdermal ] use for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); contraceptives, namely, oral contraceptives, sponges, gels, foams, creams, films, solutions, suppositories, suspensions and lotions for use in preventing HIV and other sexually transmitted infections ] ; prophylactic preparations for prevention of [ pregnancy and ] disease; gels [, foams, creams, films, solutions, suppositories, suspensions and lotions, ] for the treatment of [ viral, fungal and ] bacterial diseases, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of human immunodeficiency virus ] ; vaginal gels [ and lubricants ] for the prevention of [ pregnancy and sexually transmitted infections and ] diseases of the human reproductive systemSECTION 71 - CANCELLED—
010[ Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 20, 2023FINPFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 28, 2022INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Dec 23, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 23, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 4, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 4, 2021C71TCANCELLED SECTION 71—
Jun 7, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 6, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 16, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 27, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 7, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jun 9, 2017RFNTREFUSAL PROCESSED BY IB—
May 18, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 5, 2017CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Apr 28, 2017CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 8, 2017XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Apr 8, 2017XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 25, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 20, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
May 25, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED—
May 25, 201671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
May 20, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 2, 2016ES71TEAS SECTION 71 RECEIVED—
May 2, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 5, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 12, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 12, 2010FIMPFINAL DISPOSITION PROCESSED—
Aug 4, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 4, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 27, 2010NPUBNOTICE OF PUBLICATION—
Jan 12, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 29, 2009CNEAEXAMINERS AMENDMENT MAILED—
Dec 29, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Dec 29, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 16, 2009DOCKASSIGNED TO EXAMINER—
Sep 15, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 14, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 14, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 19, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 2, 2008CNSLLETTER OF SUSPENSION MAILED—
Dec 1, 2008CNSLSUSPENSION LETTER WRITTEN—
Nov 11, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 11, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 11, 2008ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 25, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 25, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 22, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 10, 2008OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 27, 2008OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 27, 2008OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 13, 2008NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 9, 2008CNSLLETTER OF SUSPENSION MAILED—
Jan 9, 2008CNSLSUSPENSION LETTER WRITTEN—
Dec 14, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 12, 2007CNSLLETTER OF SUSPENSION MAILED—
Jun 11, 2007CNSLSUSPENSION LETTER WRITTEN—
May 24, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
May 24, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2007ALIEASSIGNED TO LIE—
May 7, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 24, 2006RFNTREFUSAL PROCESSED BY IB—
Nov 7, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 7, 2006RFRRREFUSAL PROCESSED BY MPU—
Nov 4, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 3, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2006DOCKASSIGNED TO EXAMINER—
Oct 27, 2006NWAPNEW APPLICATION ENTERED—
Oct 26, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance